Download Full Text (3.2 MB)


  • Understanding and Managing Multiple Endocrine Neoplasia Syndromes: Endocrine tumors caused by multiple endocrine neoplasia syndromes (MEN) pose a dual threat-both from the tumors' potential for growth or metastasis and from their hormonal secretions
  • Two-Stage Resection and Improved Chemotherapy Regimens Lengthen Survival for Patients with Lever Metastasis from Colorectal Cancer
  • HOUSE CALL: Saving a Life by Donating Stem Cells: Fact about stem cell transplants
  • IN BRIEF: Study Reveals How EZH2 Protein Promotes Breast Tumor-Initiating Cell Growth

Creative Commons License

Creative Commons Attribution-Noncommercial-No Derivative Works 3.0 License
This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 3.0 License.

Publication Date



The University of Texas MD Anderson Cancer Center


Houston, Texas


Cote, Gilbert; Waguespack, Steven; Yao, James C.; Perrier, Nancy D.; Grubbs, Elizabeth; Rich, Thereasa; Lee, Jeffrey; Vauthey, Jean-Nicolas; Kopetz, Scott; Hung, Mien-chie; Multiple Endocrine Neoplasia; Proto-Oncogene Proteins c-ret; Thyroid cancer, medullary; Thyroid Neoplasms; Hyperthyroidism, Nonautoimmune; Hyperthyroidism; Calcitonin; Adrenal Gland Neoplasms; Pheochromocytoma; Epinephrine; Norepinephrine; Surgical Procedures, Operative; Genetic Diseases, Inborn; Thyroidectomy; vandetanib; Proto-Oncogene Proteins; Parathyroid Neoplasms; Pituitary Neoplasms; Neuroendocrine Tumors; Hyperparathyroidism; Gastrinoma; Hypoglycemia; Colorectal Neoplasms; Liver Neoplasms -- secondary; Fluorouracil; Levamisole; Irinotecan; Leucovorin; Oxaliplatin; Folfox protocol; Antineoplastic Combined Chemotherapy Protocols; Antibodies, Monoclonal; Cetuximab; Panitumumab; Embolization, Therapeutic; Survival Rate; Bevacizumab; Cetuximab; Stem Cell Transplantation; Cord Blood Stem Cell Transplantation; Bone Marrow Transplantation; Bone Marrow; Stem Cells; Tissue and Organ Procurement; Raf1 protein, human; Proto-Oncogene Proteins c-raf; DNA Repair; Tumor Suppressor Proteins; Rad51 Recombinase; Hypoxia-Inducible Factor 1; Tumor Microenvironment; EZH2 protein, human; Enhancer of Zeste Homolog 2 Protein; Peripheral Blood Stem Cells; Filgrastim; Sorafenib; Breast Neoplasms; AZD 6244; Benzimidazoles.


History of Science, Technology, and Medicine | Oncology

Conditions Governing Access


OncoLog, Volume 56, Number 04-05, April-May 2011